| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.00043 | 1 |